Alpha 7 Nicotinic Receptors and MAP Kinase in AD Models
About the Research Project
Program
Award Type
Standard
Award Amount
$299,920
Active Dates
April 01, 2004 - March 31, 2006
Grant ID
A2004001
Summary
One of the major advances in neurobiology in the last century was the formation of the general theory that changes in synaptic connections between neurons underlie information storage in the central nervous system (CNS). By studying the mechanisms of long-lasting synaptic plasticity in model systems, researchers can generate insights into the mechanisms of learning and memory. Dr. Sweatt’s past research indicates that four protein kinases play particularly prominent roles in synaptic plasticity and memory. These kinases are designated as PKA, PKC, CaMKII, and ERK MAPK. This project involves the role of the alpha7 nicotinic acetylcholine receptor in regulating these protein kinases. Alpha7 nicotinic acetylcholine receptors are abundant in the hippocampus and in cholinergic neurons from the basal forebrain, and these structures are particularly vulnerable to the ravages of Alzheimer’s disease. Dr. Sweatt is now testing the hypothesis that beta-amyloid peptide directly activates the alpha7 nicotinic acetylcholine receptor and leads to the disruption of memory-related biochemical processes.
Related Grants
Alzheimer's Disease Research
"Cognition in a Dish" to Develop New Alzheimer’s Therapies
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Matthias Hebisch, PhD
Current Organization
Massachusetts General Hospital
"Cognition in a Dish" to Develop New Alzheimer’s Therapies
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Matthias Hebisch, PhD
Current Organization
Massachusetts General Hospital
Alzheimer's Disease Research
Why Alzheimer’s Disease Targets Some Cells First: A Clue in the Anterior Hypothalamus
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Gowoon Son, PhD
Current Organization
Mayo Clinic Jacksonville
Why Alzheimer’s Disease Targets Some Cells First: A Clue in the Anterior Hypothalamus
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Gowoon Son, PhD
Current Organization
Mayo Clinic Jacksonville
Alzheimer's Disease Research
Probing the Novel Roles of Neuromodulators in Alzheimer’s Disease
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Fikri Birey, PhD
Current Organization
Emory University
Probing the Novel Roles of Neuromodulators in Alzheimer’s Disease
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Fikri Birey, PhD
Current Organization
Emory University